Pharmacogenomics

Pharmacogenomics is the study of the role of the genome in drug response. Its name (pharmaco- + genomics) reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics (drug absorption, distribution, metabolism, and elimination) and pharmacodynamics (effects mediated through a drug's biological targets). The term pharmacogenomics is often used interchangeably with pharmacogenetics. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response

    Related Conference of Pharmacogenomics

    September 03-04, 2026

    16th World Glycobiology Congress

    Paris, France
    September 21-22, 2026

    24th International Conference on Structural Biology

    Barcelona, Spain
    May 24-25, 2027

    23rd World Congress on Structural Biology

    Paris, France

    Pharmacogenomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in